DJIA 18,085.08 61.02 0.34%
NASDAQ 5,024.10 18.71 0.37%
S&P 500 2,115.67 7.38 0.35%
market minute promo

Pfizer (NYSE: PFE)

34.31 0.23 (0.69%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PFE $34.31 0.69%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $34.11
Previous Close $34.08
Daily Range $34.05 - $34.36
52-Week Range $27.51 - $35.53
Market Cap $210.3B
P/E Ratio 24.17
Dividend (Yield) $1.12 (3.3%)
Ex-Dividend Date
Dividend Pay Date
05/06/15
06/02/15
Volume 7,795,444
Average Daily Volume 28,331,840
Current FY EPS $2.05

Sector

Healthcare

Industry

Drug Makers

Pfizer (PFE) Description

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra. Website: http://www.pfizer.com/

News & Commentary Rss Feed

The Tiny Biotech Getting Free Lunch from Big Pharma

Portola Pharmaceuticals will soon face several important catalysts that have the potential to drive this under-the-radar stock sky high.

pSivida, Moore's Law, Pfizer, And The Next Regeneron

Chris DeMuth Jr: Event-Driven Portfolio For May 2015

Pfizer is a Good Buy Post Recent Results

Biogen Making A Breakthrough In Treating Alzheimer's

Could This Dark Horse Be Pfizer Inc.'s Next Major Acquisition?

Pfizer is reportedly considering a major acquisition soon. Here's one dark-horse buyout candidate that no one is talking about right now, but they should be.

The Top 10 Best-Selling Products In History

Will a Possible Sobi Acquisition Affect Pfizer (PFE) Stock?

Crouching Tigers, Hidden Assets - Smead Capital Management

Pfizer's Healthy Dividend Helps Against The Strong Dollar Blahs

See More PFE News...

PFE's Top Competitors

PFE $34.31 (0.69%)
Current stock: PFE
JNJ $100.33 (0.20%)
Current stock: JNJ
ROG $73.85 (-0.16%)
Current stock: ROG
GSK $46.50 (1.14%)
Current stock: GSK